Home/Filings/4/0001437749-17-009782
4//SEC Filing

Aviragen Therapeutics, Inc. 4

Accession 0001437749-17-009782

$VXRTCIK 0000072444operating

Filed

May 21, 8:00 PM ET

Accepted

May 22, 3:29 PM ET

Size

5.0 KB

Accession

0001437749-17-009782

Insider Transaction Report

Form 4
Period: 2017-05-18
PLUMB RUSSELL H
DirectorCEO & President
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-05-18$0.49/sh+20,000$9,800622,453 total
    Exercise: $0.49From: 2018-05-18Exp: 2027-05-18Common Stock (20,000 underlying)

Issuer

Aviragen Therapeutics, Inc.

CIK 0000072444

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000072444

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 3:29 PM ET
Size
5.0 KB